Lista de obras - Lucia Lopalco - Dominio Público Uruguay

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study

artículo científico publicado en 2003

A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients

artículo científico publicado en 2013

Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection

artículo científico publicado en 2009

Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection

artículo científico publicado en 2007

Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study

article

Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity

article

Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A Possible Role in the Resistance to HIV of HIV‐Exposed Seronegative Individuals

article

Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

artículo científico publicado en 2011

CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects

artículo científico publicado en 2004

CCR5: From Natural Resistance to a New Anti-HIV Strategy

artículo científico publicado en 2010

Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission

artículo científico publicado en 2013

Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?

artículo científico publicado en 2020

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside

scientific article published on 24 January 2020

Control of HIV despite the Discontinuation of Antiretroviral Therapy

article

Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines

artículo científico publicado en 1993

Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity

artículo científico publicado en 2016

Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

scientific article published on 03 August 2019

Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection

artículo científico publicado en 2016

ERK1-Based Pathway as a New Selective Mechanism To Modulate CCR5 with Natural Antibodies.

artículo científico publicado en 2015

Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

artículo científico publicado en 2014

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

artículo científico publicado en 2011

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis

artículo científico publicado en 2009

HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection

article

HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia

article

HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes.

artículo científico publicado en 2009

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

artículo científico publicado en 1999

Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance?

artículo científico publicado en 2004

Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project.

artículo científico publicado en 2000

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

article

Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.

artículo científico publicado en 2007

Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy

artículo científico publicado en 2005

Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.

artículo científico publicado en 2013

Is autoimmunity a component of natural immunity to HIV?

artículo científico publicado en 2006

Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody

artículo científico publicado en 2012

Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression

artículo científico publicado en 2006

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

artículo científico publicado en 2006

Modeling and Spectroscopic Studies of Synthetic Diazabicyclo Analogs of the HIV-1 Inhibitor BMS-378806 and Evaluation of Their Antiviral Activity

article

Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection

artículo científico publicado en 2001

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

article

Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men

article

Natural anti-CCR5 antibodies in HIV-infection and -exposure ⬇️

artículo científico publicado el 27 de enero de 2011

Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells

artículo científico publicado en 2007

Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.

artículo científico publicado en 2002

Orally exposed uninfected individuals have systemic anti-HIV responses associating with partnersʼ viral load

article

Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.

artículo científico publicado en 2012

Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.

artículo científico publicado en 2005

Protecting the initial site of viral entry: an alternative HIV vaccine target

artículo científico publicado en 2011

Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection

artículo científico publicado en 2009

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

artículo científico publicado en 2013

Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control

article

Role of CD4 and CCR5 Levels in the Susceptibility of Primary Macrophages to Infection by CCR5-Dependent HIV Type 1 Isolates

article

Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women

artículo científico publicado en 2010

Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve

artículo científico publicado en 2021

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.

artículo científico publicado en 2002

Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts

artículo científico publicado en 2010

Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

artículo científico publicado en 2014

Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1

article

Studies on propylamine transfer activity in anti-AdoDATO antibodies

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones

artículo científico publicado en 2014

The role of IL-1beta in reduced IL-7 production by stromal and epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1 infection

artículo científico publicado en 2010

The ‘immunologic advantage’ of HIV-exposed seronegative individuals

article

Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens

artículo científico publicado en 2008

Unsung Hero Robert C. Gallo

artículo científico publicado en 2009

Upregulation of Interferon-?? and RANTES in the Cervix of HIV-1-Seronegative Women With High-Risk Behavior

article

Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.

artículo científico publicado en 2012

Lista de obras de Lucia Lopalco

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study

A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients

Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection

Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection

Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study

Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity

Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A Possible Role in the Resistance to HIV of HIV‐Exposed Seronegative Individuals

Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.

CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects

CCR5: From Natural Resistance to a New Anti-HIV Strategy

Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission

Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside

Control of HIV despite the Discontinuation of Antiretroviral Therapy

Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines

Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity

Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection

ERK1-Based Pathway as a New Selective Mechanism To Modulate CCR5 with Natural Antibodies.

Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis

HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection

HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia

HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes.

Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance?

Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project.

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.

Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy

Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.

Is autoimmunity a component of natural immunity to HIV?

Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody

Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

Modeling and Spectroscopic Studies of Synthetic Diazabicyclo Analogs of the HIV-1 Inhibitor BMS-378806 and Evaluation of Their Antiviral Activity

Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men

Natural anti-CCR5 antibodies in HIV-infection and -exposure ⬇️

Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells

Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.

Orally exposed uninfected individuals have systemic anti-HIV responses associating with partnersʼ viral load

Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.

Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.

Protecting the initial site of viral entry: an alternative HIV vaccine target

Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control

Role of CD4 and CCR5 Levels in the Susceptibility of Primary Macrophages to Infection by CCR5-Dependent HIV Type 1 Isolates

Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women

Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.

Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts

Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1

Studies on propylamine transfer activity in anti-AdoDATO antibodies

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones

The role of IL-1beta in reduced IL-7 production by stromal and epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1 infection

The ‘immunologic advantage’ of HIV-exposed seronegative individuals

Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens

Unsung Hero Robert C. Gallo

Upregulation of Interferon-?? and RANTES in the Cervix of HIV-1-Seronegative Women With High-Risk Behavior

Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.